Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery.

Ther Adv Ophthalmol · 2021 · PMC8481718 · PMID 34604698

Europe PMC DOI

hedged sentence

0.1955

closest p · 3.9× alpha

0.1955

boldest claim

The sentences

a nonsignificant trendp = 0.1955not close (p > 0.1)

We noted a nonsignificant trend toward a greater reduction in medication use in the iTrack + phaco group (69%) with respect to the iTrack-alone group (36%) at 36 months ( p = 0.1955).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.